Identification of immunotherapy early treatment failure in non-small cell lung cancer (NSCLC) using a novel cell-free DNA (cfDNA) tissue-agnostic genome-wide methylome enrichment assay.Tuan Hoang, Adrian G. Sacher, Sally C. M. Lau et al.|Journal of Clinical Oncology|2025Cited by 1